“Dupilumab in Moderate-to-Severe Atopic Dermatitis: Pooled Efficacy Results from Two Identically Designed Randomized Phase 3 Trials (SOLO 1 & 2)”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s38. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/201.